Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: An open-label phase 1b/2 randomised study

Chan Yoon Cheah, David Belada, Michelle A Fanale, Andrea Janikova, Myron S Czucman, Ian W Flinn, Amy V Kapp, Avi Ashkenazi, Sean Kelley, Gordon L Bray, Scott Holden, John F. Seymour

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: An open-label phase 1b/2 randomised study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences